- Home
- IRWD vs TECK Comparison
IRWD vs TECK Comparison
Compare IRWD & TECK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRWD
- TECK
- Stock Information
- Founded
- IRWD 1998
- TECK 1913
- Country
- IRWD United States
- TECK Canada
- Employees
- IRWD N/A
- TECK N/A
- Industry
- IRWD Biotechnology: Pharmaceutical Preparations
- TECK
- Sector
- IRWD Health Care
- TECK
- Exchange
- IRWD Nasdaq
- TECK Nasdaq
- Market Cap
- IRWD 150.9M
- TECK N/A
- IPO Year
- IRWD 2010
- TECK N/A
- Fundamental
- Price
- IRWD $0.70
- TECK $34.71
- Analyst Decision
- IRWD Buy
- TECK Strong Buy
- Analyst Count
- IRWD 5
- TECK 9
- Target Price
- IRWD $4.94
- TECK $63.78
- AVG Volume (30 Days)
- IRWD 4.2M
- TECK 3.5M
- Earning Date
- IRWD 05-07-2025
- TECK 04-24-2025
- Dividend Yield
- IRWD N/A
- TECK 2.09%
- EPS Growth
- IRWD N/A
- TECK N/A
- EPS
- IRWD N/A
- TECK 0.59
- Revenue
- IRWD $317,676,000.00
- TECK $6,773,576,370.00
- Revenue This Year
- IRWD N/A
- TECK $15.27
- Revenue Next Year
- IRWD N/A
- TECK $12.55
- P/E Ratio
- IRWD N/A
- TECK $59.01
- Revenue Growth
- IRWD N/A
- TECK 125.89
- 52 Week Low
- IRWD $0.59
- TECK $28.32
- 52 Week High
- IRWD $8.23
- TECK $55.13
- Technical
- Relative Strength Index (RSI)
- IRWD 29.40
- TECK 48.03
- Support Level
- IRWD $0.88
- TECK $33.58
- Resistance Level
- IRWD $0.98
- TECK $35.57
- Average True Range (ATR)
- IRWD 0.10
- TECK 1.08
- MACD
- IRWD 0.02
- TECK 0.25
- Stochastic Oscillator
- IRWD 11.74
- TECK 54.37
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.